Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Dissolution Specifications
Products
  • Metoprolol Succinate Extended-Release Tablets
Where it was sold

Nationwide

Nationwide

Units affected
7,448 bottles
About this recall
Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceuticals, Parsippany, NJ 07054.